LOINC Code 95124-4: Sarcoma targeted gene fusion analysis Sequencing Doc (Tiss)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Sarcoma targeted gene fusion transcript analysis. It is commonly used with the system or sample type Tiss.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Both
• Method: Sequencing

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Sarcoma targeted gene fusion transcript analysis in Tissue by Sequencing
• Sarcoma targeted gene fusion transcript analysis
• Evaluation of multiple gene fusion transcripts by sequence analysis, such as by next-generation sequencing, to detect the presence of somatic sarcoma-related gene fusions in a tissue specimen. Testing is performed for the diagnosis of specific soft tissue and bone tumors (sarcomas) based on the detected gene fusions. For example, a fusion between PAX3 and FOXO1 genes indicates an alveolar rhabdomyosarcoma and the EWSR1-FLI1 gene fusion is a present in Ewing's sarcomas. The overall result summary (fusion detected/not detected) along with information about the fusions identified, fusions targeted/tested, interpretation, testing method(s) and recommendations are typically included in the report.
• Document; Finding; Findings; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Next generation sequencing; NGS; Point in time; Random; Sarcoma gene fusion analysis; Tissue; Tissue, unspecified

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions